This article is more than 5 years old. Information may no longer be current.

Fresenius recalls more than 1.8 million bottles of NaturaLyte Liquid Bicarbonate Concentrate for hemodialysis

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Fresenius Medical Care has issued a voluntary class II recall of more than 1.8 million bottles of NaturaLyte Liquid Bicarbonate Concentrate for hemodialysis because of possible bacterial contamination.

A Fresenius Medical Care spokesperson told NN&I that the product, produced in a Montreal, Canada facility, had fallen within acceptable bacterial limits for release into the market, but routine stability testing following distribution indicated that the product may eventually develop bacteria levels that exceed the allowable level. Fresenius is looking into the cause of the issue, and does not expect the recall to affect market supply.

Fresenius Medical Care recalls all Crit-Line blood chambers 

The affected lots begin with: 14DMLB, 14EMLB, 14HMLB, 14JMLB, 14KMLB, 14LMBL, 14NMLB, 14PMLB, and 14SMLB. More information on the recall is available in the FDA website. -by Rebecca Zumoff